Advanced neurostimulation treatments for treatment-resistant depression

Neurostimulation Therapies

Evidence-based options for people with treatment-resistant depression and other mental health conditions. Delivered through accredited providers with psychiatric oversight, these approaches offer alternatives when standard treatments have not been effective. These treatment options can be explored depending on clinical indications and locations, utilising affiliated service providers and networks on a case-by-case basis.

Book a Consultation

About neurostimulation treatments

Neurostimulation therapies involve targeted modulation of brain activity using techniques such as Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), and Esketamine Therapy, where appropriate. These treatments work differently from traditional antidepressants, focusing on brain circuitry involved in mood regulation rather than neurotransmitters alone.

Treatment is delivered through approved clinics or partner providers, with psychiatric assessment, referral, and oversight provided via telehealth. Protocols vary depending on the treatment type, and patients are monitored to ensure safety and effectiveness.

Eligibility Persistent symptoms despite standard treatments. Typically trialled multiple therapies (e.g. medications, psychological therapy). Suitability assessed by a psychiatrist.
Funding Some treatments may be covered under Medicare or private funding pathways. Eligibility and rebates vary by treatment type.
Frequency Varies by modality (e.g. daily sessions for several weeks for TMS, or scheduled dosing for other therapies)
Duration Sessions range from brief outpatient visits to longer monitored appointments depending on treatment
Location Delivered at accredited local clinics or partner sites
Supervision Psychiatric oversight via telehealth, with on-site clinical support

“A different approach. A broader range of options.”

Common questions

What are neurostimulation treatments and how do they work?

Neurostimulation therapies are non-invasive or minimally invasive treatments that target specific brain circuits involved in mood, cognition, and emotional regulation. Techniques such as TMS use magnetic pulses to stimulate underactive brain regions, while others may use low electrical currents or novel pharmacological approaches. These treatments are typically considered when standard therapies have not been effective.

Are these treatments covered by Medicare or the PBS?

Coverage depends on the specific therapy. Some treatments may be partially subsidised, while others involve out-of-pocket costs. Your clinician will guide you through available funding options.

What happens during a treatment session?

This varies depending on the modality. Some treatments involve short, repeated sessions over several weeks, while others require monitored administration at a clinic. Safety monitoring and follow-up are part of all treatment pathways.

How are these treatments delivered through Halcyon Health?

Halcyon Health provides assessment, referral, and ongoing psychiatric oversight via telehealth, working with accredited providers to ensure coordinated care.

When standard treatments haven’t been enough

Neurostimulation therapies may offer another path forward. Book a consultation to explore your options.